Flomerics Group PLC - Preliminary Results


Flomerics Group PLC, global supplier of simulation software to the engineering and electronics industries, today announces its results for the year ended 31 December 2006.

Key Points

  • Turnover up 24% at £14.2 million (2005 : £11.4 million). Excluding the acquisition in the year revenues up by 13%.
  • Profit before tax, amortisation of goodwill, exceptional items and share-based payment increased by 30% to £1.5 million (2005: £1.1 million).
  • Proposed dividend increased by 8% to 1.4p per share (2005 : 1.3p)
  • Cash balance at year end £2.3 million (2005: £4.1 million)
  • Acquisition in July 2006 of Nika GmbH (NIKA).
  • Asia Pacific and US revenues up by 20% and 16% respectively at constant exchange rates.
  • Revenues from the Electronics Cooling line of business (Flotherm and Flo/pcb ) increased by 11% and Flovent revenues increased by 24% at constant exchange rates.

Commenting on the results, David Mann, Chairman, said: “With a new stable of products and excellent technology, the Group is positioned to achieve strong growth in turnover and an increase in profit margin.” Enquiries:

Flomerics
Gary Carter, Chief Executive
Chris Ogle, Finance Director

020 8487 3000
Conduit PR
Laurence Read/ Christian Taylor-Wilkinson
020 7429 6666

Chairman’s Statement

Flomerics made good progress with the implementation of its growth strategy in the year ended 31 December 2006. While significant effort was devoted to the acquisition and integration of NIKA, the company achieved good increases in revenue from its traditional products in US and Asia Pacific. The management team in Europe was strengthened at the beginning of 2007. Experience of working with NIKA since the acquisition has confirmed assessments of the major contributions that its products and technology can make to the future of the Group.

Results

Total revenues were up by 24% at £14.2 million (2005:£11.4 million). Revenues, excluding those resulting from the acquisition of NIKA made during the year, grew by 13% to £12.9 million.

Profit before tax, amortisation of goodwill, exceptional items (of £222,000) and share-based payment increased by 30% to £1.5 million (2005: £1.1 million). As a result of the acquisition, which we indicated would be dilutive in the first year, earnings per share were 1.87p (2005: 5.83p). Earnings per share before amortisation of goodwill were 5.44p (2005: 6.90p).

Cash generated from operations was 0.7 million (2005: £1.8 million). £1.3 million of cash was used as part of the consideration for the acquisition. Cash balances for the group at 31 December 2006 were £2.3 million (2005: £4.1 million).

Dividend

The board is pleased with the progress being made and is proposing that the dividend should be increased by 8% to 1.4 p per share (2006:1.3p). Subject to approval at the Annual General Meeting, the dividend will be paid on 25 May 2007 to shareholders on the register at 27 April 2007.

Lines of Business and regional performance

All percentages in this section are at constant exchange rates. Revenue from our Electronics Cooling line of business (Flotherm and Flo/pcb) increased by 11%. Revenues from the Electromagnetic Products line of business (FLO/EMC and Micro-Stripes) grew by 4%. Flovent revenues were up 24% and revenues related to MicReD, acquired in 2005, were up 80%. Excluding the NIKA acquisition and the MicReD revenues, the increase in turnover by region was: Asia Pacific 20%, US 16% and Europe 2%.

Acquisition

On 5 July 2006 the Board announced the acquisition of Nika GmbH. The initial consideration was £8.8 million with potential further consideration of £3.9 million depending on the after tax results of the Group in 2007.

The acquisition of NIKA will enable the Group to sell solutions for a far wider range of applications whilst still providing the electronics sector with more specialised products and services. Other benefits include the potential to drive a higher level of sales through each of our existing offices and the shortening of the sales cycle for the new products. In the period from the acquisition to the end of the year, sales from NIKA added £1.4 million to group turnover. The acquisition has also brought some powerful new technology to the Group as well as a highly specialised product development team, which is based in Moscow.

Board Changes

On 31 December 2006 David Tatchell, the Chief Technology Officer (CTO) and former Chief Executive of the company stepped down from the Board. David will continue in his role as CTO on a part-time basis. David was the joint founder of the company in 1988 and the Board expresses its gratitude to him for his outstanding contribution to the success of the company.

In last year’s annual report we announced our intention to conduct a search for a successor to Tim Morris, Non-Executive Director and Chairman of the Audit Committee. On 24 January 2007, Tim was succeeded by Peter Teague, who has served as Finance Director of several major international enterprises and is currently Chairman of the Audit Committee of Ofcom. I thank Tim for his considerable contribution to the Board for more than ten years and, in particular, for agreeing to stay on longer than originally intended through the acquisition of NIKA.

Outlook

The acquisition of NIKA has resulted in a step-change in the Group’s potential and ambitions.

With a new stable of products and excellent technology, the Group is positioned to achieve strong growth in turnover and an increase in profit margin. As a result of the considerable investments during the last two years, including the strengthening of our management team, the directors are excited about the prospects for delivering a significant increase in value to shareholders.

David Mann Chairman

Chief Executive’s Review

2006 proved to be a transformational year for Flomerics. I can report some considerable achievements, the most significant of which was the acquisition of NIKA GmbH.

At the beginning of the year we set out to achieve three clear objectives. Our first objective was to continue to drive the top line growth of our existing product set. The second objective was to consolidate the acquisition of MicReD which we completed in 2005, and our third objective was to evaluate fresh acquisition opportunities. Acquisitions must meet our twin criteria of securing world-leading technology whilst also adding a complementary product set to our existing lines of business. I am delighted to announce that we have successfully achieved all three of these objectives.

Acquisition of NIKA GmbH

The acquisition of NIKA GmbH (NIKA) in July represented a significant move for Flomerics. NIKA is a specialist software developer that provides simulation tools for the prediction of fluid flow and heat transfer. NIKA’s principal product is EFD.Lab; a Computational Fluid Dynamics (CFD) simulation tool used by engineers in the design of a diverse range of products which includes vehicles, home appliances and electronics. EFD.Lab enables engineers to optimise their designs in the shortest possible time and is tightly integrated with the major Mechanical Computer Aided Design (MCAD) systems.

There is clear synergy between NIKA’s and Flomerics’ product applications. The client lists of both companies feature big-name companies, such as Alcatel, BAE Systems, Black & Decker, Bosch, Delphi, Intel, Mitsubishi, Thales, Samsung, Siemens and Toyota. However, NIKA’s extensive client base also includes DAF, Electrolux, Honda, Lufthansa, Miele, Olympus, Pirelli, Tyco and Volkswagen. This provides the potential to cross-sell both NIKA and Flomerics solutions into the combined client base.

Key benefits of the NIKA acquisition include:

  • Ownership of world-leading CFD technology which can be applied to improve and extend Flomerics products
  • The broadening of the Flomerics business beyond electronics applications
  • The opportunity to sell the NIKA products through existing Flomerics sales operations around the world quickly and economically
  • Significantly enhanced sales opportunities resulting from close technical integration and sales collaboration with leading MCAD companies

An acquisition such as this does not happen without a great deal of work from employees on both sides. I would therefore like to take this opportunity to thank all the Flomerics and former Nika employees for the contributions they made throughout the year.

Lines of Business

The acquisition of NIKA has led us to revaluate the way we organise and drive the success of our products. This has resulted in the establishment of three distinct areas of business focus: electronics cooling; CFD applications; and electromagnetic products.

Electronics Cooling is the largest part of our business. Flomerics is the market leader in the provision of software tools used by electrical and mechanical engineers to analyse and predict temperatures in the design of circuit boards and complete electronic systems. These software tools are based around our market-leading FLOTHERM product and now also include the MicReD family of products and the NIKA EFD product set.

CFD for Mechanical Applications extends Flomerics’ marketplace beyond the world of electronics. This line of business provides software that enables mechanical design engineers to analyse and optimise complex fluid flow and heat transfer processes across an extremely wide range of products and industries. In addition to NIKA’s EFD family of products, CFD applications also includes FLOVENT which addresses the Heating, Ventilation and Air Conditioning (HVAC) market.

Electromagnetic Products are used by engineers to simulate electromagnetic radiation. Applications include the design of wireless equipment within the telecommunications, military, automotive and aerospace industries and containing the problem of electromagnetic interference, also in these industries. Our electromagnetic products business is being given an increased level of focus with the appointment of a dedicated line of business manager.

Management Team The acquisition of NIKA has brought a number of highly skilled and experienced people into the Flomerics management team. These include Alexander Sobachkin who manages our Moscow office. This is now our largest office and the centre of EFD product development. Roland Feldhinkel, the former managing director of NIKA, now manages a newly formed product group.

We have bolstered our management team further still with the appointment of David Barry, our new European Sales Director. David brings extensive sales and management experience gained within the Computer Aided Engineering sector and will be responsible for the growth of all of our business throughout Europe.

2006 Achievements

I am delighted to be able to report on the continued improvements in performance throughout the business. Our electronics cooling business continues to perform strongly having achieved revenue growth of 11% over 2005.

Results for the electromagnetic business were less strong with only modest growth over 2005. However, the business should benefit from an increased investment in sales resources made during the later part of 2006. We have also taken steps to reduce our development costs for this line of business by moving our two electromagnetic products to a single platform.

Many of our individual products have performed extremely well. Revenues for FLOVENT are up 24% and MicReD product revenues are up by 80%. The performance of the MicReD products is especially pleasing as it demonstrates how quickly and successfully the Flomerics sales organisation has been able to adapt to selling new hardware-based solutions. The MicReD product set was extended further during 2006 with the addition of the TERALED product. This has been developed specifically in response to demand from leading LED manufacturers and provides a unique, complete solution for LED testing.

All geographic regions of our operations delivered sound performances. Growth in the US was 16%, whilst Asia-Pacific grew by 20%. Japan and South-East Asia were among our best performing territories and we anticipate continued and accelerating sales growth within these regions in the years ahead.

As I mentioned earlier, the acquisition of NIKA provides the opportunity to expand our sales and marketing activities within the US whilst achieving first-time sales within new territories. In some cases we have been able to take advantage of the sales resources and infrastructures we already have in place, whilst in other regions we have invested in new sales resources. The excellent sales results achieved during the later part of 2006 has validated our conviction that significant opportunities exist to sell NIKA’s EFD products in both new and existing territories.

Industry Collaboration

I have, in the past, emphasised the importance of strategic partnerships to the continued success of Flomerics. The value and longevity of our software solutions depend greatly on their ability to be applied to a wide variety of design tools and applications. The acquisition of NIKA has brought new or enhanced partnerships with a number of MCAD companies including Dassault Systemes and PTC. Our relationship with SolidWorks (a subsidiary of Dassault) is particularly strong and a significant share of NIKA’s revenue has come from royalties on sales of COSMOSFloWorksTM ; a CFD tool embedded within SolidWorksTM that is based on EFD.Lab technology.

The Future

2006 was a year of significant development for Flomerics. The addition of new products, new customers and new people has placed us in a strong position to achieve even greater growth across each of our areas of business focus.

With much of the investment to capitalise on the NIKA acquisition already in place, I am now looking forward to bringing to fruition the exciting growth opportunities we have created. The aim is to repeat throughout the world the same levels of success that the NIKA products have achieved within Germany.

In 2007, we begin to share the leading technologies found in Flomerics and NIKA products in order to realise continual improvements in performance and breadth of application for the benefit of customers of all our products. With a clear and determined focus on our three areas of business, the strengthening of our sales resources and a greater marketing presence for our EFD products world-wide, I look forward with confidence and enthusiasm to a successful future for Flomerics, our customers and our shareholders.

Gary Carter Chief Executive

Operating and Financial Review

Group Financial Performance

Turnover for 2006 increased by 24% at £14.2 million. Excluding revenue resulting from the acquisition of NIKA GmbH made during the year, revenues were up by 13%.

Profit before tax and amortisation of goodwill, share-based payments and exceptional items was up by 30% at £1.5 million. The charge for the year for share-based payments was £97,000. It is a new requirement of UK GAAP to make a charge for share-based payments and the 2005 accounts have been restated to include a charge for this of £66,000.

The results for 2006 have been impacted by exchange rates and the weakening of the US dollar and this is expected to continue into 2007. The average rate of exchange to the pound in 2006 was 1.843.

Exceptional costs totalled £222,000, of which approximately 50% relates to restructuring costs arising from the acquisition.

The goodwill amortisation figure of £644,000 (2005:£158,000) includes the sum of £456,000 which is attributable to the acquisition. This is a pro-rated charge as the acquisition was completed at the beginning of July 2006.

The headline tax rate is 32% (2005 restated : 4.1%). This was higher than in 2005 because the goodwill charge is not a tax deductible expense. Excluding the goodwill charge, the tax rate would have been just 14%. The tax charge has been kept low because of the use of tax credits for research and development received in the UK and the availability of tax losses in the US. All of the tax losses arising in the US have now been utilised. There are significant tax losses in NIKA but these have not been reflected in these accounts as a deferred tax asset.

The net result is that basic earnings per share for 2006 were 1.87p (2005: 5.83p). Earnings per share before amortisation of goodwill were 5.44p (2005: 6.90p)

Costs

Cost of sales, which comprise royalties paid to third-party licensors and manufacturing costs of the Group’s hardware products for the full year, amounted to 3.9% (2005: 2.5%) of revenue.

Research and development (R&D) costs have increased. This is primarily due to the acquisition of NIKA which has a large R&D facility based in Moscow. In the period since the acquisition, R&D costs in Moscow were £547,000. R&D costs accounted for 20.8% of Group revenue (2005: 19.4%) in the period.

Staff related costs are the Group’s biggest expense. These increased by 23% to £7.6 million. The average number of staff increased by 40%, from 136 to 191. At the end of the year the Group employed 235 people. At the time of the acquisition NIKA employed 72 people, 52 of which were based in Moscow.

Contribution from Nika

The profit and loss account for Nika shows an operating loss of £655,000. This includes a goodwill amortisation charge of £456,000 relating to the cost of the acquisition set out in Note 28 and certain costs which benefited the Group. For example the Chief Executive of Nika took on the role of European Sales Director following the acquisition and the development operation in Moscow undertook various tasks related to Flomerics’ legacy products. Taking these into account, it is estimated that the actual impact on the Group’s operating profit from Nika’s activities was a loss of about £100,000.

Cashflow and Financing

Cash generated from operating activities was £685,000 (2005: £1.8 million.). This was lower than the 2005 figure because a very significant amount of the Group’s turnover occurred late in the year. As a result, trade debtors were £1.4 million higher than they were at the end of 2005.

Major non-operating cashflow included cash invested in the acquisition of NIKA of £1.3 million; capital expenditure of £512,000 (2005: £380,000); deferred consideration in respect of the acquisition of MicReD made in 2005 of £165,000; and a dividend paid of £195,000 (2005:£161,000). The net decrease in cash was £1.7 million at the year end.

The Group has borrowings of £376,000 which relate to the mortgage on a freehold property that is being repaid over ten years. With a cash balance of £2.3 million, net funds are £2.0 million.

Trade debtors at the end of 2006 were £4.8 million (2005: £3.4 million). Debtor days at 31 December were 72 (2005:76.)

Share Capital

On 18 April 2006, 130,000 shares were issued to the vendors of MicReD as part of the deferred consideration under the terms of the acquisition. On 10 May 2006 50,000 shares were issued to the vendors of MicReD pursuant to the release of the retained consideration due to the vendors.

On 7 July 2006 6,293,000 shares were issued to the vendors of NIKA GmbH as part of the consideration under the terms of the acquisition. A further 1,265,000 shares were retained, and will not be issued until the expiry of the warranty period.

In order to facilitate the issue of shares to the vendors of NIKA, the Group’s authorised share capital was increased from £200,000 to £400,000. This was approved at an Extraordinary General Meeting of shareholders which was held on 5 July 2006.

Deferred Consideration

Under the terms of the acquisition of MicReD, deferred consideration was due depending on the results in 2005 and 2006. Following the performance in 2006, it is expected that the final instalment of the deferred consideration will be paid out during 2007.

Key Performance Indicators

Measures of the Group’s performance reviewed by the management include:

  • Performance against budget by turnover and contribution to profit, by region and line of business.
  • Rate of renewals of licenses.
  • New sales won and lost against the competition.

An important forward looking indicator is the level of identified business as a percentage of budget and compared to previous years.

Non-financial measures monitored include:

  • Staff turnover rates
  • Results of staff surveys
  • Enquiries to the website

Accounting Standards

The Group has adopted International Financial Reporting Standards (IFRS) with effect from 1 January 2007.

We have been assessing the impact of IFRS on our accounts. The acquisition of NIKA will be restated under IFRS 3 and a value will be attributed to the intangible assets acquired (such as customer lists and technology). The intangible assets will be amortised and the goodwill arising will be subject to an impairment review. We have had the acquisition of NIKA valued for this purpose and the effect of the new treatment has been quantified. This is subject to review by our auditors. The remaining goodwill, which related to previous acquisitions, will no longer be amortised but will be subject to an annual impairment review and subject to foreign exchange movement.

The other significant change under IFRS will be the treatment of research and development costs. Under IAS 38, if certain criteria are satisfied, the development costs must be capitalised and amortised over the anticipated period that benefits are expected. We have identified the projects that are likely to be affected by this change and are currently assessing the financial impact.

Chris Ogle Finance Director

FLOMERICS GROUP PLC CONSOLIDATED PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2006

 

Continuing      activities

           2006           £’000

 

Acquisitions

             2006           £’000

 

         Group

           2006

          £’000

 

 

         2005*

          £’000

 

 

 

 

 

Turnover

12,864

1,357

14,221

11,424

Cost of sales

(444)

_________

(106)

_________

(550)

_________

(291)

_________

 

Gross  profit

 

12,420

 

1,251

 

13,671

 

11,133

 

 

 

 

 

Administrative expenses

 

 

 

 

Research and
development cost

(2,408)

(547)

(2,955)

(2,214)

     Goodwill amortisation

(188)

(456)

(644)

(158)

     Share-based payment

(97)

-

(97)

(66)

     Exceptional restructuring
costs

(110)

-

(110)

-

     Exceptional staff costs

(112)

-

(112)

-

     Other

(8,350)

(903)

(9,253)

(7,917)

 

________

________

________

________

 

 

 

 

 

Total administrative expenses

(11,265)

(1,906)

(13,171)

(10,355)

 

________

________

________

________

 

 

 

 

 

 

1,155

(655)

500

778

Other operating income

61

-

61

66

 

________

________

________

________

 

 

 

 

 

Operating profit

1,216

(655)

561

844

 

 

 

 

 

Other interest receivable and similar income

Interest payable and similar charges

 

 

101

 

(164)

92

 

(36)

 

 

 

________

________

Profit on ordinary activities before taxation (Note 3)

 

 

 

498

 

900

Tax on profit on ordinary activities (Note 5)

 

 

(160)

_________

(37)

_________

 

 

 

 

 

Profit for the financial year

 

 

338

 

863

 

 

 

 

________

________

Earnings per share (Note 6)

 

 

           1.87p

           5.83p

Diluted earnings per share (Note 6)

 

 

           1.47p

           5.59p

* As restated (see Note 7)

FLOMERICS GROUP PLC CONSOLIDATED BALANCE SHEET AT 31 DECEMBER 2006

 

           2006

          2006

            2005*

        2005*

 

          £’000

         £’000

             £’000

        £’000

Fixed assets

 

 

 

 

Intangible assets

Tangible assets

 

 

10,041

1,709

_______

 

1,353

1,726

_______

 

 

11,750

 

3,079

Current assets

 

 

 

 

Stock

33

 

59

 

Debtors

5,467

 

3,953

 

Cash at bank and in hand

2,339

_______

 

4,081

_______

 

 

7,839

 

8,093

 

 

 

 

 

 

Creditors:  amounts falling due within one year

 

(5,205)

_______

 

 

(4,386)

_______

 

 

 

 

 

 

 

 

 

 

 

Net current assets

 

2,634

_______

 

3,707

_______

 

 

 

 

 

Total assets less current liabilities

 

 

 

14,384

 

 

6,786

Creditors: amounts falling due after more than one year

 

 

 

(305)

 

 

(377)

 

 

 

 

 

 

 

________

 

________

Net assets (Note 3)

 

14,079

_______

 

6,409

_______

 

 

 

 

 

Capital and reserves

 

 

 

 

Called up share capital

 

213

 

148

Shares to be issued

 

1,112

 

33

Share premium account

 

1,735

 

1,602

Merger reserve

 

7,185

 

892

Profit and loss account

 

3,834

 

3,734

 

 

________

 

________

Shareholders’ funds

 

14,079

_______

 

6,409

_______

* As restated (see Note 7)

FLOMERICS GROUP PLC SUMMARY CONSOLIDATED CASH FLOW STATEMENTAdministrative expenses FOR THE YEAR ENDED 31 DECEMBER 2006

 

             2006

 

        2005*

 

            £’000

 

         £’000

Operating Activities

 

 

 

Operating profit

561

 

844

Depreciation and amortisation charges

1,028

 

492

Share-based payment

97

 

66

Loss  / (gain) on disposal of fixed assets

2

 

(1)

Exchange differences

(123)

 

113

Decrease / (increase) in stocks

30

 

(6)

(Increase) / decrease in debtors

(1,081)

 

53

Increase in creditors

171

 

283

Net cash inflow from operating activities

685

 

1,844

 

 

 

 

Net cash inflow / (outflow) from returns on

 investment and servicing of finance

 

(63)

 

 

56

 

 

 

 

Tax paid

(176)

 

(126)

 

 

 

 

Net cash outflow from capital expenditure

(507)

 

(376)

 

 

 

 

Net cash paid for acquisition (including deferred consideration)

 

(1,418)

 

 

(405)

 

 

 

 

Equity dividend paid

(195)

 

(161)

 

________

 

________

Net cash inflow before financing

(1,674)

 

832

 

 

 

 

Net cash outflow from financing

(68)

 

(65)

 

________

 

________

(Decrease) / Increase in cash in the year

(1,742)

 

767

 

________

 

________

RECONCILIATION OF NET CASH FLOW TO MOVEMENT IN NET FUNDS

 

 

 

(Decrease) / Increase in cash in period

(1,742)

 

767

Cash outflow from decrease in debt and lease financing

 

68

 

 

65

 

________

 

________

Movement in net funds i